Stock listing
A40PJ7 Stock Price, News, Filings & Events — Traws Pharma, Inc.
Selected listing: A40PJ7 · LS · EUR · DE
This page tracks Traws Pharma, Inc.'s A40PJ7:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A40PJ7:LS. A40PJ7:LS is the stock-level entry point for investors researching Traws Pharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Traws Pharma, Inc. (TRAW) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
- Ticker
- A40PJ7:LS
- Asset type
- Stock
- Market cap
- $8.7M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LS
- Currency
- EUR
Traws Pharma, Inc. A40PJ7:LS stock context
This page tracks Traws Pharma, Inc.'s A40PJ7:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A40PJ7:LS. A40PJ7:LS is the stock-level entry point for investors researching Traws Pharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Traws Pharma, Inc. (TRAW) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Traws Pharma, Inc.
Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights
August 14, 2026
Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program
June 22, 2026
Traws Pharma Provides Regulatory Update on Influenza Program
June 12, 2026
Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks
May 27, 2026
Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results
May 15, 2026
Traws Pharma, Inc. earnings calls
Research Traws Pharma, Inc.
Traws Pharma, Inc. investor report
Review AI stock analysis and investor report context for A40PJ7:LS.
Traws Pharma, Inc. company profile
View the public company page for Traws Pharma, Inc. on 6ix.
Traws Pharma, Inc. news
Read company news and market updates connected to Traws Pharma, Inc..
Traws Pharma, Inc. investor events
Find investor webinars, events, and replay context for Traws Pharma, Inc..
Alternate listings
TRAW:NASDAQ
US · USD
Alternate listing for Traws Pharma, Inc.; the primary context on this page is A40PJ7:LS.
TRAW:BOATS
US · USD
Alternate listing for Traws Pharma, Inc.; the primary context on this page is A40PJ7:LS.
0T20:GETTEX
DE · EUR
Alternate listing for Traws Pharma, Inc.; the primary context on this page is A40PJ7:LS.
0T20:MUN
DE · EUR
Alternate listing for Traws Pharma, Inc.; the primary context on this page is A40PJ7:LS.
0T20:FWB
DE · EUR
Alternate listing for Traws Pharma, Inc.; the primary context on this page is A40PJ7:LS.